These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 27569899)

  • 1. Beneficial effect of hydroxychloroquine on cutaneous vasculitis in a Japanese patient with systemic lupus erythematosus.
    Kibune N; Shimomura Y; Hasegawa A; Saeki T; Umemori Y; Abe R
    J Dermatol; 2017 Apr; 44(4):e52-e53. PubMed ID: 27569899
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic efficacy and adverse events of hydroxychloroquine administration in Japanese systemic/cutaneous lupus erythematosus patients.
    Kishi C; Motegi SI; Yasuda M; Ishikawa O
    J Dermatol; 2018 Aug; 45(8):1020-1022. PubMed ID: 30133802
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of rheumatic diseases: current status and future prospective. Topics: II. Immunosuppressant/antirheumatic drugs; 10. Hydroxychloroquine].
    Yokogawa N
    Nihon Naika Gakkai Zasshi; 2011 Oct; 100(10):2960-5. PubMed ID: 22175138
    [No Abstract]   [Full Text] [Related]  

  • 4. Plaque-like Cutaneous Lupus Mucinosis as the First Sign of Systemic Lupus Erythematosus.
    Gao M; Sheng N; Yang X; Jiang Y
    Acta Derm Venereol; 2020 Feb; 100(4):adv00048. PubMed ID: 31774542
    [No Abstract]   [Full Text] [Related]  

  • 5. Hydroxychloroquine modulates elevated expression of S100 proteins in systemic lupus erythematosus.
    Wakiya R; Kameda T; Ueeda K; Nakashima S; Shimada H; Mansour MF; Kato M; Miyagi T; Miyatake N; Kadowaki N; Dobashi H
    Lupus; 2019 Jun; 28(7):826-833. PubMed ID: 31068068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with the use of hydroxychloroquine for the treatment of lupus erythematosus.
    Momose Y; Arai S; Eto H; Kishimoto M; Okada M
    J Dermatol; 2013 Feb; 40(2):94-7. PubMed ID: 23216212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population Pharmacokinetics of Hydroxychloroquine in Japanese Patients With Cutaneous or Systemic Lupus Erythematosus.
    Morita S; Takahashi T; Yoshida Y; Yokota N
    Ther Drug Monit; 2016 Apr; 38(2):259-67. PubMed ID: 26587870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertrophic lupus erythematosus successfully treated with hydroxychloroquine.
    Yoshimoto N; Shinkuma S; Ujiie H; Nomura T; Fujita Y; Abe R; Shimizu H
    J Dermatol; 2017 Mar; 44(3):e48-e49. PubMed ID: 27237449
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity.
    Ugarte A; Porta S; Ríos R; Martinez-Zapico A; Ortego-Centeno N; Agesta N; Ruiz-Irastorza G
    Lupus; 2018 Sep; 27(10):1718-1722. PubMed ID: 29635998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chilblain lupus erythematosus.
    Patel S; Hardo F
    BMJ Case Rep; 2013 Nov; 2013():. PubMed ID: 24285807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ototoxicity due to hydroxychloroquine: report of two cases.
    Johansen PB; Gran JT
    Clin Exp Rheumatol; 1998; 16(4):472-4. PubMed ID: 9706431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vesico-bullous subacute cutaneous lupus erythematosus--an uncommon entity successfully treated with dapsone and hydroxychloroquine.
    Pinto-Almeida T; Sanches M; Alves R; Selores M
    Dermatol Online J; 2012 Aug; 18(8):13. PubMed ID: 22948063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of lupus skin involvement with quinacrine and hydroxychloroquine.
    Cavazzana I; Sala R; Bazzani C; Ceribelli A; Zane C; Cattaneo R; Tincani A; Calzavara-Pinton PG; Franceschini F
    Lupus; 2009 Jul; 18(8):735-9. PubMed ID: 19502270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapsed hydroxychloroquine induced thrombocytopenia in a systemic lupus erythematosus patient.
    Antón Vázquez V; Pascual L; Corominas H; Giménez Torrecilla I
    Reumatol Clin; 2017; 13(5):294-296. PubMed ID: 27263963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to hydroxychloroquine in Japanese patients with systemic lupus erythematosus using the cutaneous lupus erythematosus disease area and severity index (CLASI).
    Yokogawa N; Kato Y; Sugii S; Inada S
    Mod Rheumatol; 2012 Apr; 22(2):249-55. PubMed ID: 21842436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effect of hydroxychloroquine on cutaneous lupus erythematosus in a Japanese girl.
    Yamamoto T; Hiraiwa T
    J Dermatol; 2014 Apr; 41(4):357-9. PubMed ID: 24617496
    [No Abstract]   [Full Text] [Related]  

  • 17. Hydroxychloroquine in systemic lupus erythematosus (SLE).
    Ponticelli C; Moroni G
    Expert Opin Drug Saf; 2017 Mar; 16(3):411-419. PubMed ID: 27927040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why all systemic lupus erythematosus patients should be given hydroxychloroquine treatment?
    Costedoat-Chalumeau N; Leroux G; Piette JC; Amoura Z
    Joint Bone Spine; 2010 Jan; 77(1):4-5. PubMed ID: 20022788
    [No Abstract]   [Full Text] [Related]  

  • 19. Variable presentations of subacute cutaneous lupus erythematosus.
    Balma-Mena A; Ho N
    J Cutan Med Surg; 2010; 14(4):195-8. PubMed ID: 20642992
    [No Abstract]   [Full Text] [Related]  

  • 20. A rare case of unilateral discoid lupus erythematosus mimicking lupus vulgaris.
    Verma P; Pathania S; Kubba A
    BMJ Case Rep; 2017 Nov; 2017():. PubMed ID: 29122902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.